首页> 外文期刊>药物分析学报(英文) >Gas chromatography-mass spectrometry method for determination of β-propiolactone in human inactivated rabies vaccine and its hydrolysis analysis
【24h】

Gas chromatography-mass spectrometry method for determination of β-propiolactone in human inactivated rabies vaccine and its hydrolysis analysis

机译:气相色谱-质谱法测定人灭活狂犬病疫苗中β-丙内酯及其水解分析

获取原文
获取原文并翻译 | 示例
       

摘要

A simple method was established for the determination of β-propiolactone (BPL) in human inactivated rabies vaccine by gas chromatography-mass spectrometry (GC-MS). The determination was performed on an Agilent HP-INNOWAX (30m × 0.32mm i.d., 0.25 μm) capillary column at the temperature of 80 °C. Electrospray ionization (ESI) was used by selective ion detection at m/z 42. The temperature for ESI source and inlet was set at 230 °C and 200 °C, respectively. Helium was used as the carrier gas at a flow rate of 25.1 mL/min. The total run time was 8 min. Acetonitrile and other components in the sample did not interfere with the determination of BPL. The results showed good linearity of BPL in the range of 0.50–10.01 μg/mL, with the limit of detection and the limit of quantification of 0.015 μg/mL and 0.050 μg/mL, respectively. Satisfactory precision was achieved for the current developed method. The method was applied to detect 6 batches of vaccine samples, and the results indicated that the target analyte BPL was present in three batches of unpurified samples, but was not detected in the purified samples, indicating the test samples were qualified. The established method was proved to be simple, versatile and sensitive, which can meet the requirements of quality control of BPL in human inactivated rabies vaccine.
机译:建立了一种通过气相色谱-质谱法(GC-MS)测定人灭活的狂犬病疫苗中β-丙内酯(BPL)的简单方法。测定是在80°C的Agilent HP-INNOWAX(30m×0.32mm i.d.,0.25μm)毛细管柱上进行的。电喷雾电离(ESI)通过m / z 42进行选择性离子检测。ESI源和入口的温度分别设置为230°C和200°C。氦气以25.1 mL / min的流速用作载气。总运行时间为8分钟。样品中的乙腈和其他成分不会干扰BPL的测定。结果表明,BPL在0.50–10.01μg/ mL范围内具有良好的线性,检测限和定量限分别为0.015μg/ mL和0.050μg/ mL。当前开发的方法达到了令人满意的精度。该方法用于6批次疫苗样品的检测,结果表明三批未纯化样品中均存在目标分析物BPL,但在纯化样品中未检测到目标分析物BPL,表明测试样品合格。实践证明,所建立的方法简便,通用,灵敏,可以满足人灭活狂犬病疫苗中BPL质量控制的要求。

著录项

  • 来源
    《药物分析学报(英文)》 |2018年第006期|373-377|共5页
  • 作者单位

    School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China;

    School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China;

    Liaoning Medical Device Test Institute, Shenyang 110179, China;

    Shenyang Wellwolf Pharmaceutical Science and Technology Co. Ltd, Shenyang 110022, China;

    School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:25:51
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号